Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

OMASIEL H COMRIE-REINERT

Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Psychiatric/Mental Health

NPI
1649721713
CMS profile
11051711
Location
LANCASTER, PA

General Payments · PY2021–2024

$4,457.84

  • Reported across 66 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$2,327.31

35 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $2,306.97 33
Education $20.34 2

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $147.21 4
PY2022 $1,017.12 11
PY2023 $966.20 16
PY2024 $2,327.31 35

Payment records · PY2024 (35)

Sorted by paying entity, then date · as published by CMS

Program year 2024 202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $78.91 01/11/2024 Food and Beverage Undisputed 01/23/2026 1106942375 CMS
ABBVIE INC. $25.85 02/07/2024 Food and Beverage Undisputed 01/23/2026 1106942377 CMS
ABBVIE INC. $124.00 03/22/2024 Food and Beverage Undisputed 01/23/2026 1106942379 CMS
ABBVIE INC. $14.02 06/12/2024 Food and Beverage Undisputed 01/23/2026 1106942381 CMS
ABBVIE INC. $19.37 07/20/2024 Food and Beverage Undisputed 01/23/2026 1106942383 CMS
ABBVIE INC. $80.56 09/26/2024 Food and Beverage Undisputed 01/23/2026 1106942385 CMS
Axsome Therapeutics, Inc. $100.00 04/01/2024 Food and Beverage Undisputed 01/23/2026 1148398881 CMS
Axsome Therapeutics, Inc. $86.65 06/18/2024 Food and Beverage Undisputed 01/23/2026 1148398883 CMS
Axsome Therapeutics, Inc. $124.00 07/12/2024 Food and Beverage Undisputed 01/23/2026 1148398885 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $36.36 02/08/2024 Food and Beverage Undisputed 01/23/2026 1118095856 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $10.17 02/09/2024 Education Undisputed 01/23/2026 1118095852 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $10.17 02/09/2024 Education Undisputed 01/23/2026 1118095854 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $125.00 11/21/2024 Food and Beverage Undisputed 01/23/2026 1118095858 CMS
E.R. Squibb & Sons, L.L.C. $106.65 10/03/2024 Food and Beverage Undisputed 01/23/2026 1101582798 CMS
E.R. Squibb & Sons, L.L.C. $111.11 11/11/2024 Food and Beverage Undisputed 01/23/2026 1101582806 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $117.18 04/04/2024 Food and Beverage Undisputed 01/23/2026 1143410590 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $6.46 05/04/2024 Food and Beverage Undisputed 01/23/2026 1143410593 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $6.46 05/04/2024 Food and Beverage Undisputed 01/23/2026 1143410597 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $6.46 05/05/2024 Food and Beverage Undisputed 01/23/2026 1143410601 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $6.46 05/05/2024 Food and Beverage Undisputed 01/23/2026 1143410604 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $6.46 05/05/2024 Food and Beverage Undisputed 01/23/2026 1143410608 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $6.46 05/05/2024 Food and Beverage Undisputed 01/23/2026 1143410612 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $124.99 06/19/2024 Food and Beverage Undisputed 01/23/2026 1143410616 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $125.00 09/12/2024 Food and Beverage Undisputed 01/23/2026 1143410620 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $115.32 11/14/2024 Food and Beverage Undisputed 01/23/2026 1143410623 CMS
Neurocrine Biosciences, Inc. $125.00 10/17/2024 Food and Beverage Undisputed 01/23/2026 1150920890 CMS
Otsuka America Pharmaceutical, Inc. $124.99 02/20/2024 Food and Beverage Undisputed 01/23/2026 1119048392 CMS
Otsuka America Pharmaceutical, Inc. $57.03 04/16/2024 Food and Beverage Undisputed 01/23/2026 1119048394 CMS
Otsuka America Pharmaceutical, Inc. $61.06 06/04/2024 Food and Beverage Undisputed 01/23/2026 1119048396 CMS
Otsuka America Pharmaceutical, Inc. $28.78 10/10/2024 Food and Beverage Undisputed 01/23/2026 1119048398 CMS
Tempus AI, Inc $96.64 12/13/2024 Food and Beverage Undisputed 01/23/2026 1150179667 CMS
Teva Pharmaceuticals USA, Inc. $68.98 01/29/2024 Food and Beverage Undisputed 01/23/2026 1151740960 CMS
Teva Pharmaceuticals USA, Inc. $125.01 06/11/2024 Food and Beverage Undisputed 01/23/2026 1151741046 CMS
Teva Pharmaceuticals USA, Inc. $18.14 08/22/2024 Food and Beverage Undisputed 01/23/2026 1151741072 CMS
Teva Pharmaceuticals USA, Inc. $47.61 08/22/2024 Food and Beverage Undisputed 01/23/2026 1151741074 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.